EP
Eversept Partners Portfolio holdings
AUM
$992M
1-Year Return
2.54%
This Quarter Return
+0.43%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$992M
AUM Growth
+$109M
(+12%)
Cap. Flow
+$89.1M
Cap. Flow
% of AUM
8.98%
Top 10 Holdings %
Top 10 Hldgs %
53.33%
Holding
74
New
18
Increased
22
Reduced
22
Closed
6
Top Buys
| 1 |
Vaxcyte
PCVX
|
+$24.1M |
| 2 |
Revvity
RVTY
|
+$20.4M |
| 3 |
UnitedHealth
UNH
|
+$18.9M |
| 4 |
Illumina
ILMN
|
+$18.9M |
| 5 |
Avantor
AVTR
|
+$18.9M |
Top Sells
| 1 |
HealthEquity
HQY
|
+$20.5M |
| 2 |
HCA Healthcare
HCA
|
+$20.1M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$18.5M |
| 4 |
Natera
NTRA
|
+$16.4M |
| 5 |
Protagonist Therapeutics
PTGX
|
+$14.9M |
Sector Composition
| 1 | Healthcare | 99.94% |
| 2 | Financials | 0.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Gossamer Bio
GOSS
$707M
| $2.09M | 0.19% |
1,695,762
-2,201,079
| -56% | -$2.71M |
|
52
Structure Therapeutics
GPCR
$1.2B
| $2.06M | 0.19% |
+99,338
| New | +$2.06M |
|
53
Relay Therapeutics
RLAY
$700M
| $1.85M | 0.17% |
+533,409
| New | +$1.85M |
|
54
Sutro Biopharma
STRO
$77.2M
| $1.64M | 0.15% |
2,292,261
| – | – |
|
55
Maravai LifeSciences
MRVI
$376M
| $1.54M | 0.14% |
640,673
-301,781
| -32% | -$727K |
|
|
BCYC
56
Bicycle Therapeutics
BCYC
$485M
| $1.47M | 0.14% |
+211,469
| New | +$1.47M |
|
|
AUTL
57
Autolus Therapeutics
AUTL
$367M
| $1.39M | 0.13% |
610,231
+266,284
| +77% | +$607K |
|
58
InflaRx
IFRX
$107M
| $1.3M | 0.12% |
1,640,430
-35,548
| -2% | -$28.1K |
|
59
Pennant Group
PNTG
$850M
| $1.13M | 0.1% |
+37,980
| New | +$1.13M |
|
60
Karyopharm Therapeutics
KPTI
$53.8M
| $1.11M | 0.1% |
257,154
| – | – |
|
|
ITOS
61
DELISTED
iTeos Therapeutics
ITOS
| $1.09M | 0.1% |
109,324
-110,872
| -50% | -$1.11M |
|
62
Fortrea Holdings
FTRE
$909M
| $1.08M | 0.1% |
219,384
-73,891
| -25% | -$365K |
|
63
Puma Biotechnology
PBYI
$229M
| $826K | 0.08% |
240,688
-35,100
| -13% | -$120K |
|
64
Arcturus Therapeutics
ARCT
$489M
| $629K | 0.06% |
+48,364
| New | +$629K |
|
65
eHealth
EHTH
$115M
| $558K | 0.05% |
128,322
+39,102
| +44% | +$170K |
|
|
MODV
66
DELISTED
ModivCare
MODV
| $312K | 0.03% |
+100,000
| New | +$312K |
|
67
AC Immune
ACIU
$241M
| $205K | 0.02% |
100,752
| – | – |
|
|
68
Neurocrine Biosciences
NBIX
$14B
| – | – |
-167,243
| Closed | -$18.5M |
|
69
Novavax
NVAX
$1.29B
| – | – |
-365,523
| Closed | -$2.34M |
|
70
Invesco QQQ Trust
QQQ
$369B
| – | – |
-24,003
| Closed | -$11.3M |
|
71
SPDR S&P 500 ETF Trust
SPY
$664B
| – | – |
0
| – | – |
|
72
Teleflex
TFX
$5.76B
| – | – |
-56,630
| Closed | -$7.83M |
|
73
Xoma
XOMA
$442M
| – | – |
-45,017
| Closed | -$897K |
|
74
Align Technology
ALGN
$9.64B
| – | – |
-49,277
| Closed | -$7.83M |
|